摘要
Silymarin flavonolignans are well-known agents that typically possess antioxidative, anti-inflammatory, and hepatoprotective functions. Recent studies have also documented the antiviral activities of silymarin and its derivatives against several viruses, including the flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus. This review will describe some of the latest preclinical and clinical studies detailing the antiviral profiles of silymarin and its derivatives, and discuss their relevance for antiviral drug development.
| 原文 | 英語 |
|---|---|
| 文章編號 | 1552 |
| 期刊 | Molecules |
| 卷 | 24 |
| 發行號 | 8 |
| DOIs | |
| 出版狀態 | 已發佈 - 4月 19 2019 |
ASJC Scopus subject areas
- 分析化學
- 化學（雜項）
- 分子醫學
- 藥學科學
- 藥物發現
- 物理與理論化學
- 有機化學
